Skip to Main Content
Contribute Try STAT+ Today

WASHINGTON — For years, former President Trump threatened to use foreign prices as a cap for what Americans should pay for drugs. Now that he’s left office without implementing the controversial proposal, states are picking up where his administration left off.

An array of lawmakers in Hawaii, North Dakota, Maine, Oklahoma, and other states are hoping they can make a version of the Trump administration plan, which focused on Medicare prices, work at the state level. Unlike that proposal and a similar bill from Sen. Bernie Sanders (I-Vt.), however, several of the state efforts could potentially become law in 2021.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Not going to happen. Politicians love to talk about proposals that won’t happen.
    Ever hear of the Center for Medicare & Medicaid? Ever hear about Congress?

Comments are closed.